Log in to save to my catalogue

endocannabinoid system in obesity and type 2 diabetes

endocannabinoid system in obesity and type 2 diabetes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69356691

endocannabinoid system in obesity and type 2 diabetes

About this item

Full title

endocannabinoid system in obesity and type 2 diabetes

Author / Creator

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Journal title

Diabetologia, 2008-08, Vol.51 (8), p.1356-1367

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

More information

Scope and Contents

Contents

Endocannabinoids (ECs) are defined as endogenous agonists of cannabinoid receptors type 1 and 2 (CB₁ and CB₂). ECs, EC anabolic and catabolic enzymes and cannabinoid receptors constitute the EC signalling system. This system participates in the control of lipid and glucose metabolism at several levels, with the possible endpoint of the accumulation...

Alternative Titles

Full title

endocannabinoid system in obesity and type 2 diabetes

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69356691

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69356691

Other Identifiers

ISSN

0012-186X

E-ISSN

1432-0428

DOI

10.1007/s00125-008-1048-2

How to access this item